vTv Therapeutics Inc (VTVT)
26.52
+0.76
(+2.93%)
USD |
NASDAQ |
Apr 26, 16:00
26.52
0.00 (0.00%)
After-Hours: 17:25
vTv Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2022 | -0.0209 |
| September 30, 2022 | -0.0336 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.0263 |
| September 30, 2021 | -0.0295 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.001 |
| September 30, 2020 | -0.0461 |
| June 30, 2020 | -0.0653 |
| March 31, 2020 | -0.0713 |
| December 31, 2019 | -0.1259 |
| September 30, 2019 | -0.1867 |
| June 30, 2019 | -0.217 |
| March 31, 2019 | -0.2283 |
| December 31, 2018 | -0.1896 |
| Date | Value |
|---|---|
| September 30, 2018 | -0.414 |
| June 30, 2018 | -0.2667 |
| March 31, 2018 | -0.1335 |
| December 31, 2017 | -0.1297 |
| September 30, 2017 | -0.1417 |
| June 30, 2017 | -0.1789 |
| March 31, 2017 | -0.1519 |
| December 31, 2016 | -0.1216 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -0.6855 |
| March 31, 2015 | -0.6378 |
| December 31, 2014 | -0.5957 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.217
Minimum
Jun 2019
--
Maximum
Mar 2021
-0.0549
Average
-0.0295
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Altimmune Inc | 0.00 |
| Palatin Technologies Inc | 0.00 |
| Oragenics Inc | -- |
| Viking Therapeutics Inc | -- |
| G1 Therapeutics Inc | 1.457 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.02M |
| Total Liabilities (Quarterly) | 29.57M |
| Shareholders Equity (Quarterly) | -24.68M |